{"id":"https://openalex.org/A5010839283","orcid":"https://orcid.org/0000-0002-2786-8331","observed_orcids":["https://orcid.org/0000-0002-2786-8331"],"display_name":"Emily Back","raw_author_names":["Back, Emily","E Back","Emily Back"],"full_name":"Back, Emily","works_count":11,"cited_by_count":18,"summary_stats":{"2yr_mean_citedness":1.6,"h_index":2,"i10_index":1},"ids":{"openalex":"https://openalex.org/A5010839283","orcid":"https://orcid.org/0000-0002-2786-8331","observed_orcids":["https://orcid.org/0000-0002-2786-8331"]},"affiliations":[{"institution":{"id":"https://openalex.org/I4405283779","ror":"https://ror.org/028m49k59","display_name":"DHT.health (United Kingdom)","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405283779"]},"years":[2026,2025]}],"last_known_institutions":[{"id":"https://openalex.org/I4405283779","ror":"https://ror.org/028m49k59","display_name":"DHT.health (United Kingdom)","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405283779"]}],"topics":[{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","count":9,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11280","display_name":"Hemophilia Treatment and Research","count":8,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","count":6,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10841","display_name":"Economic and Environmental Valuation","count":2,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10554","display_name":"Hemoglobinopathies and Related Disorders","count":1,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"topic_share":[{"id":"https://openalex.org/T11280","display_name":"Hemophilia Treatment and Research","value":8.66e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","value":3.12e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","value":1.59e-05,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10841","display_name":"Economic and Environmental Valuation","value":1.17e-05,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11917","display_name":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","value":1.09e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"x_concepts":[{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.9089000225067139},{"id":"2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","score":0.536918580532074},{"id":"2778780528","wikidata":"https://www.wikidata.org/wiki/Q709360","display_name":"Von Willebrand disease","score":0.4896000027656555},{"id":"187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","score":0.351500004529953},{"id":"2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","score":0.32749998569488525}],"counts_by_year":[{"year":2023,"works_count":1,"oa_works_count":1,"cited_by_count":0},{"year":2024,"works_count":2,"oa_works_count":2,"cited_by_count":3},{"year":2025,"works_count":2,"oa_works_count":0,"cited_by_count":11},{"year":2026,"works_count":6,"oa_works_count":2,"cited_by_count":4}],"display_name_alternatives":["Back, Emily","E Back","Emily Back"],"block_key":"e back","works_api_url":"https://api.openalex.org/works?filter=author.id:A5010839283","awards_count":0,"awards_api_url":"https://api.openalex.org/awards?filter=investigators.author.id:A5010839283","updated_date":"2026-11-10T14:30:39","created_date":"2023-03-08T00:00:00"}